SiTime Corporation Free cash flow increased by 37.6% to $17.87M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1500.4%, from -$1.28M to $17.87M. Over 2 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 11.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.21M | $15.34M | $13.85M | $12.58M | $5.52M | $9.86M | -$4.25M | -$1.18M | -$2.74M | -$6.71M | -$2.40M | -$1.28M | -$2.89M | $26.31M | $12.99M | $17.87M |
| QoQ Change | — | +578.5% | -9.7% | -9.2% | -56.1% | +78.5% | -143.1% | +72.2% | -132.9% | -144.4% | +64.2% | +46.8% | -126.7% | >999% | -50.6% | +37.6% |
| YoY Change | — | — | — | — | +272.1% | -21.6% | — | -112.0% | — | — | +43.5% | -8.3% | -5.4% | +492.2% | +641.6% | >999% |